Consultant to biotech and medical device companies. Diane Mellett qualified in law in both US and UK. Diane provides advice to biotechnology companies in commercial contract and intellectual property matters. She was formerly General Counsel for Cambridge Antibody (CAT) Technology and led the US NASDAQ listing of that company. During her time at CAT, she led a successful defence of a contractual dispute with Abbott Pharmaceuticals (now Abbvie) covering the company’s major collaboration partnership covering Humira®, the most successful revenue generating antibody therapy in the pharmaceutical industry to date.